九十岁及以上人群骨质疏松筛查的范围综述
常见主题包括现有筛查指南有效性评估、新型筛查工具(含骨折风险计算器)的效用、衰弱与多病共存的作用以及治疗率与差异。结论指出该人群筛查与管理研究不足,现行指南与临床决策存在明显差距。
要点
- 九十岁及以上人群骨质疏松筛查与管理的研究证据严重不足。
- 现行指南推荐65岁以上初始筛查,但未提供年龄相关监测指导。
- 该人群衰弱与多病共存影响骨质疏松评估,需纳入未来预测模型。
核心结论
- 九十岁及以上人群骨质疏松筛查与管理研究匮乏,现行指南与临床决策存在明显差距。
主要发现
- 纳入研究常见主题为评估现有筛查指南有效性、新型骨质疏松筛查工具(含骨折风险计算器)的效用、衰弱与多病共存的作用、治疗率报告及管理差异。
关键数值与推荐
- 现行指南推荐所有65岁及以上患者进行初始筛查,但未提供年龄相关监测的进一步指导。
临床怎么用
- 照护高龄老人时需注意现行指南与临床决策间的明显差距,并关注衰弱与多病共存对骨质疏松管理的影响。
局限性
- 九十岁及以上人群作为主要研究对象的文献很少,证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As the United States population continues to age and advancements contribute to enhanced life expectancy, care for nonagenarians (adults aged 90 years and older) is as important as ever. A prominent concern within healthcare for the oldest old remains the occurrence of fragility fractures, and subsequent 1-year mortality, making prevention key. As it stands, current guidelines recommend initial screening for all patients aged 65 years or older without further guidance regarding age-related surveillance. The purpose of this scoping review is to better understand the current literature surrounding the benefits and shortcomings of osteoporosis screening and intervention among nonagenarians. METHODS: A comprehensive literature search following PRISMA guidelines was conducted using Cochrane, CINAHL, Embase, SCOPUS, Web of Science, and PubMed-MEDLINE from 2018 to present. The search yielded 3346 studies. RESULTS: Twenty-one articles met inclusion criteria. Common themes were identified among included studies: evaluation of the effectiveness of existing screening guidelines, utility of new osteoporotic screening tools including fracture risk calculators, the role of frailty and multimorbidity in osteoporosis, and reporting of treatment rates and disparities in the management of osteoporosis. CONCLUSIONS: Osteoporosis screening and management has been poorly studied within the population of nonagenarians. When caring for the oldest old, there is an apparent discrepancy between current guidelines and clinical decision making. We highlight the need for future research centering on nonagenarians as the primary study group in order to establish factors which should be incorporated into future predictive models and screening recommendations.
引用
- Mosher HA, Remer HB, Berwitz KT, et al. Screening for Osteoporosis in Nonagenarians: A Scoping Review. J Am Geriatr Soc. 2025. PMID: 40616267. doi:10.1111/jgs.19621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。